Tag: Athersys

Athersys provides update on ischaemic stroke and haemorrhagic trauma trials of...

Athersys, the company developing MultiStem (invimestrocel)—an off-the-shelf stem cell treatment intended for critical care indications, including acute ischaemic stroke, trauma and other inflammatory conditions—has provided...